Pharmaceutical Raw Materials
Veterinary API
Pharmaceutical Intermediates
Biochemicals
Pharmaceutical Excipients
Other Chemical Drugs
Blood System Drugs
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Antibiotics
Synthetic Anti Infective Drugs
Antipyretic Analgesics
Antiallergic Drugs
Fluid, Electrolyte, and Acid-Base Balance
Vitamins and Minerals Medicines
Urinary System Drugs
Digestive System Drugs
Antiparasitic Drugs
Anesthetic Agents
Hormones and Endocrine Drugs
Diagnostic Agents
Circulatory System Drugs
Immune System Medication
Anti Stress Drugs
Inhibitors
Drug Metabolism
Specialty Drugs
Feed Drug Additive
CAS:56-92-8
Molecular Formula:C5H11Cl2N3
Alias
More Information
Bichlorhydrated’Histamine; Edihydrochlorideavailablefrom1Kgto100Kg.; Histaminedichloride; 1H-Imidazole-4-Ethanamine Dihydrochloride; 2-(1H-Imidazol-4-Yl)Ethanamine; 2-(1H-Imidazol-4-Yl)Ethanamine Dihydrochloride
Brief Introduction
Histamine dihydrochloride is used for continuous remission and prevention of relapse after first remission in adult patients with acute myeloid leukemia (AML).
CAS:1029712-80-8
Molecular Formula:C23H17FN6O
Alias
More Information
Benzamide,2-Fluoro-N-Methyl-4-[7-(6-Quinolinylmethyl)Imidazo[1,2-B][1,2,4]Triazin-2-Yl]-; 2-Fluoro-N-Methyl-4-[7-[(Quinolin-6-Yl)Methyl]Imidazo[1,2-B]-[1,2,4]Triazin-2-Yl]Benzamide Capmatinib;
Brief Introduction
Camatinib can effectively inhibit the proliferation and migration of c-met dependent tumor cells and induce apoptosis. It has antitumor activity.
CAS:317318-70-0
Molecular Formula:C21H18F3NO3S2
Alias
More Information
GW501516; GW 501516; GW-501516; GSK-516; Cardarine; GW1516; GW 1516; GW-1516; 2-(4-((2-(4-(Trifluoromethyl)Phenyl)-4-Methylthiazol-5-yl)Methylthio)-2-Methylphenoxy)Acetic acid; 2-(2-Methyl-4-(((4-Methyl-2-(4-(Trifluoromethyl)Phenyl)Thiazol-5-yl)Methyl)thio)Phenoxy)Acetic acid; 2-[2-Methyl-4-[[4-Methyl-2-[4-(Trifluoromethyl)Phenyl]-1,3-Thiazol-5-yl]Methylsulfanyl]Phenoxy]Acetic acid; GW-516; {2-Methyl-4-[({4-Methyl-2-[4-(Trifluoromethyl)Phenyl]-1,3-Thiazol-5-yl}Methyl)Sulfanyl]Phenoxy}Acetic acid; 2-{2-Methyl-4-[({4-Methyl-2-[4-(Trifluoromethyl)Phenyl]-1,3-Thiazol-5-yl}Methyl)Sulfanyl]Phenoxy}Acetic acid; GSK 516; 2-[2-Methyl-4-[[[4-Methyl-2-[4-(Trifluoromethyl)Phenyl]-5-Thiazolyl]Methyl]thio]Phenoxy]Acetic Acid; Benzenesulfonylchloride,4-(2-Methylpropyl)-(9CI); (2-Methyl-4-(((4-Methyl-2-(4-(Trifluoromethyl)Phenyl)-1,3-Thiazol-5-YL)Methyl)THIO)Phenoxy)Acetic ACID; {2-Methyl-4-{{4-Methyl-2-[4-(Trifluoromethyl)Phenyl]-5-Thiazolyl}Methylthio}Phenoxy}Acetic acid, Analytical Standard; {4-[({4-Methyl-2-[4-(Trifluoromethyl)Phenyl]-1,3-Thiazol-5-yl}Methyl)Sulfanyl]-2-Methylphenoxy}Acetic acid; 2-(2-Methyl-4-((5-Methyl-2-(4-(Trifluoromethyl)Phenyl)Thiazol-4-yl)Methylthio)Phenoxy)Acetic acid;GW 501516; 2-{2-Methyl-4-[({4-Methyl-2-[4-(Trifluoromethyl)Phenyl]-1,3-Thiazole-5-yl}Methyl)Sulfanyl]Phenoxy}Acetic acid; Acetic acid, (2-Methyl-4-(((4-Methyl-2-(4-(Trifluoromethyl)Phenyl)-5-Thiazolyl)Methyl)thio)Phenoxy)-; Acetic acid, 2-[2-Methyl-4-[[[4-Methyl-2-[4-(Trifluoromethyl)Phenyl]-5-Thiazolyl]Methyl]thio]Phenoxy]-
Brief Introduction
Endurobol is a PPARδ receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s, was entered into clinical development as a drug candidate for metabolic diseases and cardiovascular diseases, and was abandoned in 2007 because animal testing showed that the drug caused cancer to develop rapidly in several organs.
CAS:58579-51-4
Molecular Formula:C10H8Cl3N3O
Alias
More Information
Anagrelide HCL; Agrylin; Agrelin; Thromboreductin; Xagrid; Anagrelide (Hydrochloride); Anagrelid Hydrochlorid; 6,7-Dichloro-5,10-Dihydroimidazo[2,1-b]Quinazolin-2(3H)-one Hydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo[2,1-b]Quinazolin-2(3H)-one Hydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo(2,1-b)-Quinazolin-2(3H)-one Monohydrochloride; Anagrelide Hydrochloride Hydrate; Xagrid (TN); Imidazo(2,1-b)Quinazolin-2(3H)-one, 6,7-Dichloro-1,5-Dihydro-, Monohydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo(2,1-b)Quinazolin-2(3H)-one Hydrochloride; 6,7-Dichloro-3,5-Dihydro-1H-Imidazo[2,1-b]Quinazolin-2-one;Hydrochloride; 6,7-Dichloro-5,10-Dihydro-3H-Imidazo[2,1-b]Quinazolin-2-one;Hydrochloride; C10H7Cl2N3O.ClH; Imidazo[2,1-b]Quinazolin-2(3H)-one, 6,7-Dichloro-1,5-Dihydro-, Monohydrochloride; Anagrelide Hydrocholoride; C10H7Cl2N3O.HCl; 6,7-Dichloro-5,10-Dihydro-3H-Imidazo[2,1-b]Quinazolin-2-one Hydrochloride; Anagrelide Hydrochloride (USP); Anagrelide Hydrochloride- Bio-X; 6,7-Dichloro-1H,2H,3H,5H-Imidazolidino[2,1-b]Quinazolin-2-one Hydrochloride; Anagrelide Hydrochloride Anhydrous; Imidazo[2,6,7-Dichloro-1,5-Dihydro-, Monochloride; 6,7-Dichloro-5,10-Dihydro-3H-Imidazo[2,1-b]Quinazolin-2-one HCl; 6,7-Dichloro-2H,3H,5H,10H-Imidazo[2,1-b]Quinazolin-2-one Hydrochloride; 6,7-Dichloro-3,5-Dihydroimidazo[2,1-b]Quinazolin-2(1H)-one Hydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo(2,1-.BETA.)-Quinazolin-2(3H)-ONE Monohydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo(2,1-b)-Quinazolin-2(3H)-one Monohydrochloride ; 6,7-Dichloro-1,5-Dihydroimidazo[2,1-b]Quinazolin-2(3H)-one Monohydrochloride;Anagrelide Hydrochloride; Imidazo(2,1-.BETA.)Quinazolin-2(3H)-ONE, 6,7-Dichloro-1,5-Dihydro-, Monohydrochloride
Brief Introduction
Anagrelide Hydrochloride is a phosphodiesterase inhibitor with antiplatelet activity. Used as an antithrombocythemic.
CAS:827022-33-3
Molecular Formula:C26H35N7O6S
Alias
More Information
PD0332991 Isethionate; PD 0332991 Isethionate; Palbociclib (PD0332991) Isethionate; Palbociclib (Isethionate); 6-Acetyl-8-Cyclopentyl-5-Methyl-2-((5-(Piperazin-1-yl)Pyridin-2-yl)Amino)Pyrido[2,3-d]Pyrimidin-7(8H)-one 2-Hydroxyethanesulfonate; 6-Acetyl-8-Cyclopentyl-5-Methyl-2-((5-(Piperazin-1-yl)Pyridin-2-yl)Amino)Pyrido[2,3-d]Pyrimidin-7(8H)-one 2-Hydroxyethane-1-Sulfonate
Brief Introduction
PD 0332991 Isethionate is a selective inhibitor of cyclin dependant kinases CDK4 and CDK6 used in the treatment of cancer patients.
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!